NCT03596372 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT03596372
Title	Study of BAY1834942 in Patients With Solid Tumors
Recruitment	Completed
Gender	both
Phase	Phase I
Variant Requirements	No
Sponsors	Bayer
Indications	gastroesophageal junction adenocarcinoma head and neck squamous cell carcinoma bile duct cancer urinary bladder cancer breast cancer cervical cancer colorectal cancer stomach cancer Advanced Solid Tumor lung non-small cell carcinoma pancreatic cancer esophageal cancer
Therapies	BAY1834942
Age Groups:	senior \| adult
Covered Countries	USA \| CAN

Filter rows:

Showing 1 to 4 of 4 entries

Facility	City	State	Zip	Country	Details
National University Hospital	Singapore		119074	Singapore	Details
Princess Margaret Hospital-University Health Network	Toronto	Ontario	M5G 2M9	Canada	Details
Sarah Cannon Research Institute	Nashville	Tennessee	37203	United States	Details
University of Texas MD Anderson Cancer Center	Houston	Texas	77030	United States	Details

Showing 1 to 4 of 4 entries

Filter rows:

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field

NCT03596372Clinical Trial Detail